semaglutide + tirzepatide TrimRX Tirzepatide vs. Semaglutide: Which is

Microdose options are available for a more affordable plan

Zepbound (tirzepatide) is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition, as an adjunct to a reduced-calorie diet and increased physical activity

Electrolytes, glucose, and osmolality were assessed in plasma and urine at the screening visit as well as during the evaluation visits

However, the effect of tirzepatide on appetite and food intake was assessed in multiple clinical trials, with results indicating a general improvement in food- and appetite-related assessments, with details provided in Table S1